258 related articles for article (PubMed ID: 11574678)
21. Synthesis, cellular uptake and HIV-1 Tat-dependent trans-activation inhibition activity of oligonucleotide analogues disulphide-conjugated to cell-penetrating peptides.
Turner JJ; Arzumanov AA; Gait MJ
Nucleic Acids Res; 2005; 33(1):27-42. PubMed ID: 15640444
[TBL] [Abstract][Full Text] [Related]
22. Modified (PNA, 2'-O-methyl and phosphoramidate) anti-TAR antisense oligonucleotides as strong and specific inhibitors of in vitro HIV-1 reverse transcription.
Boulmé F; Freund F; Moreau S; Nielsen PE; Gryaznov S; Toulmé JJ; Litvak S
Nucleic Acids Res; 1998 Dec; 26(23):5492-500. PubMed ID: 9826777
[TBL] [Abstract][Full Text] [Related]
23. Hairpin antisense oligonucleotides containing 2'-methoxynucleosides with base-pairing in the stem region at the 3'-end: penetration, localization, and Anti-HIV activity.
Kuwasaki T; Hosono K; Takai K; Ushijima K; Nakashima H; Saito T; Yamamoto N; Takaku H
Biochem Biophys Res Commun; 1996 Nov; 228(2):623-31. PubMed ID: 8920960
[TBL] [Abstract][Full Text] [Related]
24. Correction of aberrant pre-mRNA splicing by antisense oligonucleotides in beta-thalassemia Egyptian patients with IVSI-110 mutation.
El-Beshlawy A; Mostafa A; Youssry I; Gabr H; Mansour IM; El-Tablawy M; Aziz M; Hussein IR
J Pediatr Hematol Oncol; 2008 Apr; 30(4):281-4. PubMed ID: 18391696
[TBL] [Abstract][Full Text] [Related]
25. Morpholino and phosphorothioate antisense oligomers compared in cell-free and in-cell systems.
Summerton J; Stein D; Huang SB; Matthews P; Weller D; Partridge M
Antisense Nucleic Acid Drug Dev; 1997 Apr; 7(2):63-70. PubMed ID: 9149841
[TBL] [Abstract][Full Text] [Related]
26. Overview of alternative oligonucleotide chemistries for exon skipping.
Saleh AF; Arzumanov AA; Gait MJ
Methods Mol Biol; 2012; 867():365-78. PubMed ID: 22454073
[TBL] [Abstract][Full Text] [Related]
27. Selective inhibition of mutant Ha-ras mRNA expression by antisense oligonucleotides.
Monia BP; Johnston JF; Ecker DJ; Zounes MA; Lima WF; Freier SM
J Biol Chem; 1992 Oct; 267(28):19954-62. PubMed ID: 1400312
[TBL] [Abstract][Full Text] [Related]
28. Vectorization of morpholino oligomers by the (R-Ahx-R)4 peptide allows efficient splicing correction in the absence of endosomolytic agents.
Abes S; Moulton HM; Clair P; Prevot P; Youngblood DS; Wu RP; Iversen PL; Lebleu B
J Control Release; 2006 Dec; 116(3):304-13. PubMed ID: 17097177
[TBL] [Abstract][Full Text] [Related]
29. Improved cellular uptake of antisense peptide nucleic acids by conjugation to a cell-penetrating peptide and a lipid domain.
Shiraishi T; Nielsen PE
Methods Mol Biol; 2011; 751():209-21. PubMed ID: 21674333
[TBL] [Abstract][Full Text] [Related]
30. Antisense 2'-O-methyloligoribonucleotides hybridized to RNA block a nuclear, ATP-dependent 3'-5' exonuclease.
Dominski Z; Ferree P; Kole R
Antisense Nucleic Acid Drug Dev; 1996; 6(1):37-45. PubMed ID: 8783794
[TBL] [Abstract][Full Text] [Related]
31. A comparative analysis of peptide-delivered antisense antibiotics using diverse nucleotide mimics.
Ghosh C; Popella L; Dhamodharan V; Jung J; Dietzsch J; Barquist L; Höbartner C; Vogel J
RNA; 2024 May; 30(6):624-643. PubMed ID: 38413166
[TBL] [Abstract][Full Text] [Related]
32. Systematic Approach to Developing Splice Modulating Antisense Oligonucleotides.
Aung-Htut MT; McIntosh CS; Ham KA; Pitout IL; Flynn LL; Greer K; Fletcher S; Wilton SD
Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31614438
[TBL] [Abstract][Full Text] [Related]
33. A specificity comparison of four antisense types: morpholino, 2'-O-methyl RNA, DNA, and phosphorothioate DNA.
Stein D; Foster E; Huang SB; Weller D; Summerton J
Antisense Nucleic Acid Drug Dev; 1997 Jun; 7(3):151-7. PubMed ID: 9212905
[TBL] [Abstract][Full Text] [Related]
34. Specific inhibition of influenza virus RNA polymerase and nucleoprotein genes expression by liposomally endocapsulated antisense phosphorothioate oligonucleotides: penetration and localization of oligonucleotides in clone 76 cells.
Hatta T; Takai K; Nakada S; Yokota T; Takaku H
Biochem Biophys Res Commun; 1997 Mar; 232(2):545-9. PubMed ID: 9125219
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of cell-penetrating peptides (CPPs) as vehicles for intracellular delivery of antisense peptide nucleic acid (PNA).
Bendifallah N; Rasmussen FW; Zachar V; Ebbesen P; Nielsen PE; Koppelhus U
Bioconjug Chem; 2006; 17(3):750-8. PubMed ID: 16704214
[TBL] [Abstract][Full Text] [Related]
36. Absolute bioavailability of 2'-O-(2-methoxyethyl)-modified antisense oligonucleotides following intraduodenal instillation in rats.
Geary RS; Khatsenko O; Bunker K; Crooke R; Moore M; Burckin T; Truong L; Sasmor H; Levin AA
J Pharmacol Exp Ther; 2001 Mar; 296(3):898-904. PubMed ID: 11181922
[TBL] [Abstract][Full Text] [Related]
37. 2'-O-methyl-modified phosphorothioate antisense oligonucleotides have reduced non-specific effects in vitro.
Yoo BH; Bochkareva E; Bochkarev A; Mou TC; Gray DM
Nucleic Acids Res; 2004; 32(6):2008-16. PubMed ID: 15064360
[TBL] [Abstract][Full Text] [Related]
38. Antiproliferative effects of steric blocking phosphorodiamidate morpholino antisense agents directed against c-myc.
Hudziak RM; Summerton J; Weller DD; Iversen PL
Antisense Nucleic Acid Drug Dev; 2000 Jun; 10(3):163-76. PubMed ID: 10905553
[TBL] [Abstract][Full Text] [Related]
39. Conjugates of antisense oligonucleotides with the Tat and antennapedia cell-penetrating peptides: effects on cellular uptake, binding to target sequences, and biologic actions.
Astriab-Fisher A; Sergueev D; Fisher M; Shaw BR; Juliano RL
Pharm Res; 2002 Jun; 19(6):744-54. PubMed ID: 12134943
[TBL] [Abstract][Full Text] [Related]
40. Cell cycle-dependent distribution and specific inhibitory effect of vectorized antisense oligonucleotides in cell culture.
Hélin V; Gottikh M; Mishal Z; Subra F; Malvy C; Lavignon M
Biochem Pharmacol; 1999 Jul; 58(1):95-107. PubMed ID: 10403523
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
